RxDoctor Payments Data

Dana Pittel

Acute Care · Freeland, MINPI 1295490290

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,040in general payments, 2019–2025

Across 181 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$560
  • Johnson & Johnson$510
  • Regeneron Healthcare Solutions, Inc.$324
  • Sanofi$289
  • Arcutis Biotherapeutics, Inc.$216
  • Pfizer$181
  • plus $961 from 15 others

What the payments were for

  • Food & beverage$2,93597%
  • Education$1053%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,040 in reported general payments places this provider in the 90th percentile of 567 acute care providers in Michigan.

See all acute care providers in Michigan

Medicare billing

Part B allowed, 2024
$34,696
Medicare patients
189
Services billed
776

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Unoready PenSecukinumab12$89,920
Dupixent PenDupilumab21$81,371
Ketoconazole143$2,554
Clindamycin Phosphate73$1,989
Clobetasol Propionate63$1,770
Halobetasol Propionate21$1,159
Betamethasone Valerate32$1,079
Tretinoin18$690
Doxycycline Monohydrate29$467
Imiquimod13$294
Spironolactone52$265
Mupirocin38$252
Triamcinolone Acetonide49$243

Paid to pharmacies, not to this prescriber.

Other acute care in Freeland

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →